# China NMPA Drug Inspection - Guangxi Cenxi Anyangtang Pharmaceutical Co., Ltd. - Drynaria fortunei

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangxi-cenxi-anyangtang-pharmaceutical-co-ltd/5dd6b693-2151-4e78-bc7a-d051fb2542ee/
Source feed: China

> China NMPA drug inspection for Guangxi Cenxi Anyangtang Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Drynaria fortunei. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Guangxi Cenxi Anyangtang Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Drynaria fortunei
- Inspection Finding: [Properties], [Identification] (1) Microscopic identification, (2) Thin-layer chromatography
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/guangxi-cenxi-anyangtang-pharmaceutical-co-ltd/733d04c9-dbb0-4220-90c0-c6f20a876dee/